Ledger.Open graph →
SEC Form D · filed November 24, 2025

Kamal Therapeutics, Inc

Offering
$17.3M
Sold
$13.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Mark De Souza · Chestnut Hill, MAExec · DirectorPhilip Reilly · Boston, MADirectorJohn Parker · San Juan Capistrano, CADirectorMark De Souza · Chestnut Hill, MAExec · DirectorPhilip Reilly · Boston, MADirectorJohn Parker · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗